CVS Health Co. (NYSE:CVS) Shares Sold by Archer Investment Corp

Archer Investment Corp cut its holdings in CVS Health Co. (NYSE:CVS) by 26.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 25,951 shares of the pharmacy operator’s stock after selling 9,140 shares during the quarter. Archer Investment Corp’s holdings in CVS Health were worth $1,165,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. AMF Tjanstepension AB lifted its stake in shares of CVS Health by 124.1% during the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock worth $3,882,000 after buying an additional 34,198 shares during the period. Czech National Bank grew its stake in CVS Health by 7.2% during the 3rd quarter. Czech National Bank now owns 256,430 shares of the pharmacy operator’s stock valued at $16,124,000 after purchasing an additional 17,206 shares during the last quarter. Brookstone Capital Management raised its stake in shares of CVS Health by 4.6% in the third quarter. Brookstone Capital Management now owns 62,589 shares of the pharmacy operator’s stock worth $3,936,000 after purchasing an additional 2,764 shares during the last quarter. CWM LLC lifted its holdings in shares of CVS Health by 14.1% during the third quarter. CWM LLC now owns 76,241 shares of the pharmacy operator’s stock worth $4,794,000 after purchasing an additional 9,435 shares during the period. Finally, Hexagon Capital Partners LLC increased its holdings in CVS Health by 3.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator’s stock worth $331,000 after buying an additional 178 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Evercore ISI upped their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. UBS Group increased their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research report on Tuesday, December 3rd. Finally, Mizuho lowered their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. One analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $68.12.

CVS Health Trading Down 2.7 %

CVS opened at $54.20 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company’s 50 day simple moving average is $51.02 and its two-hundred day simple moving average is $56.04. The firm has a market capitalization of $68.21 billion, a price-to-earnings ratio of 13.76, a price-to-earnings-growth ratio of 0.62 and a beta of 0.61. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period last year, the company earned $2.21 EPS. Analysts expect that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.91%. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.